Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

Abstract Background Blood loss and deep vein thrombosis (DVT) are important complications after total knee arthroplasty (TKA). Topical tranexamic acid (TXA) effectively reduces wound bleeding but may elevate the risk of DVT. In contrast, rivaroxaban potently prevents DVT but has been associated with...

Full description

Bibliographic Details
Main Authors: Yong Tae Kim, Min Wook Kang, Joon Kyu Lee, Young Min Lee, Joong Il Kim
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Musculoskeletal Disorders
Subjects:
Total knee replacement
Tranexamic acid
Rivaroxaban
Blood loss
Transfusion
Wound complication
Online Access:http://link.springer.com/article/10.1186/s12891-018-2151-2

Internet

http://link.springer.com/article/10.1186/s12891-018-2151-2

Similar Items